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ABSTRACT 
 
A diet rich in vegetables and unsaturated fatty acids is associated with a lower risk of major 
diseases including cardiovascular disease, type 2 diabetes and chronic inflammation. Yet, despite 
extensive research, the active component(s) responsible for these effects has not been pinpointed 
and studies with single nutrients have been largely unsuccessful. Recent research from our 
laboratory and elsewhere suggests that the inorganic anion nitrate (NO3-), especially abundant in 
green leafy vegetables, is converted in our bodies to nitrite (NO2-) and then further to nitric oxide 
(NO). The latter is a central signalling molecule with a number of beneficial effects in the 
cardiovascular- and gastrointestinal systems. Ingested nitrate is absorbed to the blood and mixed 
with nitrate from endogenous sources formed by NO synthases (NOS). Circulating nitrate is 
actively transported and accumulated in the salivary glands and excreted with saliva. Oral 
commensal bacteria play a surprisingly important role in nitrate bioactivation by reducing salivary 
nitrate to the more reactive nitrite anion. The nitrate-nitrite-NO pathway is now emerging as a 
significant source of NO, in addition to classical endogenous formation of this gas by NOS.  
In this thesis we have specifically explored the role of nitrate and nitrite in modulation of 
inflammation and in regulation of gastrointestinal mucus formation. In addition we have also 
studied effects of conjugated linoleic acid (CLA), another dietary constituent with proposed anti-
inflammatory effects. 
The results show that nitrite and dietary nitrate can reduce leukocyte recruitment during acute 
inflammation in the microcirculation. Dietary nitrate also prevented NSAID-provoked small 
intestinal inflammation in a process dependent on oral nitrate-reducing bacteria. Although strong 
anti-inflammatory effects were observed with dietary nitrate, the ability to clear an infection was 
not impaired. Dietary nitrate, nitrite and CLA were further demonstrated to alleviate inflammation 
in a mouse model of colitis. The protective effect seen with CLA involved upregulation of trefoil 
factor 3 (TFF3) expression through activation of peroxisome proliferator-activated receptor 
gamma (PPARγ) in the colon mucosa. Furthermore, dietary nitrite also had therapeutic effects in 
already established colonic inflammation, possibly mediated by maintaining the colonic mucus 
layer and promoting healing of colon epithelial cells. Finally, we demonstrate that the firmly 
adherent gastric mucus layer, normally present in conventional mice, was almost absent in germ 
free mice. In addition, a reduced gastric mucus layer was also observed in mice treated with broad 
spectrum antibiotics. While treatment with nitrate increased the mucus thickness further in 
conventional mice it had no effects in germ free mice, again demonstrating the essential role of 
oral bacteria in bioactivation of nitrate. Remarkably however, when the germ free mice were fed a 
low dose of nitrite, resembling what would normally be generated in saliva by bacteria, the gastric 
mucus thickness increased dramatically. This suggests that commensal oral bacteria modulate 
gastric homeostasis via physiological recycling of nitrate, originally derived from NOS.   
In conclusion, the studies in this thesis demonstrate that dietary nitrate, nitrite and CLA play a 
direct role in the regulation of inflammatory responses, both locally in the microcirculation and in 
the gastrointestinal tract. These results may have implications for future dietary recommendations 
in prevention and treatment of inflammatory disorders.  
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1 INTRODUCTION 
1.1 Diet and health 
The link between diet and health has achieved increased attention during the recent 
decades and has led to a growing consumer awareness regarding the nutritional value of 
food. As with the Mediterranean or the traditional Japanese diet, a high intake of fruit, 
vegetables and unsaturated fatty acids is associated with a lower risk for cardiovascular 
disease (CVD) and type 2 diabetes mellitus (1-6). The mechanisms of the protective 
effects were initially explained by the abundance of vitamins and antioxidants in these 
foods (7), but the active nutrients have not yet been determined. The strongest 
associations with protective effects have interestingly been found with diets high in green 
leafy vegetables (1, 4, 8). Paradoxically, these vegetables also have the highest 
concentrations of inorganic nitrate which is just about the only natural substance in 
vegetables that has been pointed out as being harmful. This is due to the suggested link 
between dietary nitrate and increased risk of cancer, first reported more than 50 years 
ago. However, these proposed harmful effects have not been proven by any human 
epidemiological studies (9). At the same time, green leafy vegetables have recently been 
ranked as one of the healthiest choice of vegetables, again supposedly due to their high 
content of vitamins and antioxidants (10). An emerging field of research on dietary nitrate 
and nitrite during the last decade has demonstrated highly surprising beneficial effects of 
these anions, thereby slowly changing the negative overall view. These salutary effects 
are due to the conversion of nitrate and nitrite in our bodies to nitric oxide (NO) and other 
bioactive nitrogen oxides with physiological effects. In this thesis we have continued to 
explore health effects of dietary nitrate, nitrite and fatty acids, with a focus on control of 
inflammation. Inflammation in various forms represents a major global health problem 
and is the underlying cause of a number of major chronic diseases. 
1.2 Endogenous formation of nitric oxide  
Before the recent discovery that nitrate and nitrite from the diet can be reduced to NO, 
endogenous production of NO by specific enzymes was thought to be the only pathway of 
formation. NO is produced by the nitric oxide synthases (NOSs), a family of enzymes 
that exist in three isoforms, neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) 
(11). These enzymes produce NO from the amino acid L-arginine with molecular oxygen 
as a co-substrate (Fig. 1). NO mediates a broad spectrum of signalling and regulatory 
functions in mammalian biology, such as nerve transmission, host defence and 
vasoregulation (11-13). The classical signalling mechanism of NO is mediated through 
binding to the heme-containing guanylyl cyclase (sGC) with subsequent increased 
formation of the second messenger 3',5'-cyclic guanosine monophosphate (cGMP). In 
turn, this leads to decreased intracellular calcium and relaxation of vascular smooth 
muscle cells (14, 15). The discovery of NO as a signalling molecule in the cardiovascular 
system elicited the Nobel Prize in Physiology or Medicine in 1998. However, prior to the 
identification of NO as an endogenous vasodilator, the endpoint had been utilized for 
more than a century with the use of organic nitrates, such as glyceryl trinitrate (GTN) to 
treat angina pectoris and high blood pressure. Organic nitrates (RO-NO2) release NO and 
have potent acute vasodilatory effects. A drawback with longterm use of these substances 
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is the development of tolerance and possible development of endothelial dysfunction with 
increased production of reactive oxygen species (ROS) (16, 17).  
NO is a very short-lived molecule due to its high reactivity with other molecules, and is 
rapidly oxidized into nitrite and nitrate in blood and tissues (Fig. 1). With the formation 
of nitrite and nitrate, the metabolism of NO was thought to be completed and these were 
for a long time considered to be inactive end products. It has been known since the 1970s 
that nitrate (NO3
-
) could be reduced to nitrite (NO2
-
) by oral bacteria (18). However, a 
novel discovery was made in the mid-1990s by two independent research groups (19, 20) 
who demonstrated that NO could be formed by reduction of nitrite in the acidic stomach. 
Thus, nitrate and nitrite tuned out not to be merely inert end products but actually 
substrates for the regeneration of NO. The formation of gastric NO from nitrite is 
suggested to occur in a series of non-enzymatic chemical reactions, with the intermediate 
formation of nitrous acid (HNO2) and dinitrogen trioxide (N2O3) (20). 
1. NO2
-
 + H
+
  HNO2  
2. 2HNO2  H2O + N2O3  
3. N2O3  ·NO + ·NO2 
 
Soon after this discovery, the conversion of nitrite to NO was observed also in the 
ischemic heart (21). This led to the important understanding that alternative routes of NO-
formation existed in addition to the generation from NOSs; both in the gastric 
compartment and systemically (Fig. 1).    
     
Figure 1. Overview of a mammalian nitric oxide (NO) cycle with oxidation and reduction 
of nitrate, nitrite and NO. 
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1.3 Dietary sources of nitrate and nitrite  
Various forms of nitrogen are essential in the biology of plants and all other living 
organisms, and the process of nitrogen cycling in nature is heavily dependent on bacteria. 
Atmospheric nitrogen gas (N2) undergoes fixation by bacteria and is converted into 
ammonium (NH4
+
) which is further oxidized to nitrite and nitrate. Nitrate in the soil is 
then taken up by plants and transported from the roots to the leaves. The levels of nitrate 
in plants are dependent on many factors, including the amount of sunlight, temperature 
and access to nitrogen. Therefore, the amount of nitrate absorbed by different plants 
varies greatly with origin and season of growth (22). Vegetables are the dominant source 
of nitrate ingested by mammals which correspond to 60-80% of nitrate intake (23), and 
green leafy vegetables have particularly high nitrate concentrations. The highest 
concentrations are found in rucola, spinach and beet root, which contain on average well 
over 100g/kg in fresh weight. Also celery, fennel, rhubarb and radish are high in nitrate. 
Potatoes have  quite low levels of this anion, but may contribute substantially to the total 
nitrate intake due to the high consumption of this vegetable in a normal Western diet (22). 
Since nitrate is water soluble, processing vegetables in various ways including washing, 
peeling and cooking can substantially reduce the nitrate content (23). In contrast to 
nitrate, the intake of nitrite originates mainly from foods where it is added as a 
preservative. Even with this ingestible source, around 80% of our exposure to nitrite is 
dependent on in vivo conversion of ingested nitrate (24). 
1.3.1 Circulation of dietary nitrate 
As in the circulation of nitrogen in plants described above, bacteria play a crucial role in 
the reduction of nitrate and nitrite also in mammalian biology. Ingested nitrate is 
efficiently absorbed from the upper gastrointestinal (GI), with a bioavailability of around 
100% (25). In the blood, nitrate originating from dietary sources and from oxidation of 
endogenous NO by NOSs is then mixed. Fasting plasma levels of nitrate are around 20-
40µM, but increases several fold after nitrate intake (26). A major part of the nitrate is 
excreted by the kidneys, though up to 25% is actively absorbed and accumulated in the 
salivary glands (27). This leads to a 10-20 times higher concentration of nitrate in human 
saliva than in plasma (26) (Fig. 2). The reason and the mechanism behind this 
accumulation of salivary nitrate are still not fully understood, but it seems to involve a 
specific transport protein named sialin, functioning by co-transporting NO3
-
/H
+ 
(28). 
Secreted salivary nitrate is reduced to nitrite in the oral cavity in a process dependent on 
commensal oral bacteria (29, 30). The swallowed nitrite is then further non-enzymatically 
metabolized to NO and other nitrogen oxides by the low pH in the stomach, a process that 
is enhanced by polyphenols and ascorbate (19, 31-33). However, much of the nitrite also 
escapes this reduction and enters the systemic circulation where it is mixed with nitrite 
generated by NOS. The plasma concentration of nitrite is around 50-100nM during 
fasting conditions and is also increased substantially after nitrate intake (26). Circulating 
nitrite can then be reduced to NO by various enzymes in blood and tissues, including 
haem-proteins and xanthine oxidoreductase (XOR) (Fig. 1) (22, 34, 35). Even though 
some nitrate can be reduced systemically to nitrite by mammalian processes (34), the 
bacterial conversion seems to play a more effective role in nitrate metabolism (29, 36).  
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The now acknowledged alternative generation of NO from the nitrate-nitrite-NO pathway 
is suggested to function as an important back-up system for NOS-dependent generation of 
this gas. Especially during conditions of low pH and hypoxia, this pathway will ensure 
sufficient formation of NO to maintain vascular homeostasis. In fact, while the oxygen-
dependent NO generation from NOS is compromised under hypoxia, the nitrate-nitrite-
NO pathway is instead greatly enhanced (37, 38).  
 
Figure 2. The enterosalivary circulation of ingested nitrate in humans. Figure adapted 
from (22). 
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1.3.2 Adverse effects of nitrate and nitrite 
The knowledge about inorganic nitrate and its potential effects in improving 
cardiovascular disorders has been utilized since 700 BC by the Chinese. In the western 
world, the practice of using inorganic nitrate and nitrite in CVD started in the late 19
th
 
century and lasted until the early parts of 20
th
 century. However, this therapeutic regimen 
was abandoned with the view that nitrite might have toxic effects by reacting with 
secondary amines to form nitrosamines (16, 17). Animal experiments with long-term 
exposure to nitrosamines had earlier been shown to give rise to an increased incidence 
hepatic tumours (39). With this, the concerns arose that this reaction might also occur in 
humans. Although numerous studies have examined the risk of nitrate/nitrite in the 
development of human tumours, including gastric cancer, the results are still not clear. A 
number of international and governmental agencies have now concluded that there are 
inadequate evidence for carcinogenicity of dietary nitrate in humans or animals (9, 23). 
However, there is still no consensus regarding the risk of cancer from nitrite in food (9, 
24). Other adverse effects with ingestion of high doses of nitrate are the formation of 
metheamoglobin in infants, named the “blue baby syndrome”. With the reduction of 
nitrate to nitrite, the ferrous iron in oxyhemoglobin is oxidized, thereby forming 
metheamoglobin which has less ability to bind oxygen, leading to reduced oxygen 
delivery to tissues. Infants under six months of age are more susceptible to this condition 
due to  lower levels of the reducing enzyme which converts metheamoglobin back to 
oxyhemoglobin (16). With reports of methemoglobinemia in infants and the potential 
carcinogenic effects, major restrictions have been made by governmental agencies to 
decrease the amounts of nitrate and nitrite in the drinking water. All this has also 
contributed to an overall negative view of nitrate and nitrite. However, with the last two 
decades of intensive research on the health benefits of inorganic nitrate, the therapeutic 
potential off this anion against disease has become evident. Focus is now slowly shifting 
from the toxic properties of nitrate to its desirable biological effects.  
1.3.3 Emerging health effects of nitrate and nitrite 
Numerous studies have reported therapeutic effects of nitrate and nitrite administration 
since the  existence of a complete reverse pathway of nitrate being converted to NO was 
proven (22, 26). The effects of nitrite in the cardiovascular system has especially been 
investigated (40). In particular, nitrite has been shown to protect against damage caused 
by ischemia-reperfusion in various organs (8, 41), as first shown in the heart by Webb 
and colleagues (42). Dietary nitrate has also been increasingly studied, demonstrating 
reduction in blood pressure in healthy volunteers, both with sodium nitrate (43) and a 
natural source in the form of beet root juice (44). A surprising effect of increased athletic 
performance has also been observed after ingestion of nitrate in humans, which is 
suggested to be a result of a reduction of mitochondrial oxygen consumption (45, 46). In 
animal studies, a great number of biological effects have been demonstrated by nitrate 
and nitrite administration (22). In the GI-tract, gastric nitrite has been demonstrated to 
increase gastric mucosal blood flow and mucus thickness (47). Along with this, dietary 
nitrate administration has shown to be protective against experimentally induced ulcers 
(48, 49). The anti-inflammatory effects of nitrate and nitrite have also recently started to 
be investigated. It was shown in the early 1990s that NO had an inhibitory effect on 
leucocyte adhesion (50, 51), an event probably mediated by activation of sGC (52). 
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Similar effects were seen by Stokes et al (53) with dietary nitrite after inducing vascular 
inflammation in mice by a high-cholesterol diet. Indications of reduced kidney 
inflammation with dietary nitrate have also been demonstrated in rats subjected to a high-
salt diet mediating renal damage and hypertension (54). Furthermore, dietary nitrate has 
been shown to reverse features of the metabolic syndrome that develop in mice lacking 
endogenous NO synthesis by eNOS, such as  body weight, visceral fat, improved glucose 
metabolism and plasma triglycerides (55).  
Many of the biological effects seen with nitrate and nitrite are associated with formation 
of NO and NO-related substances. However, it has also been suggested that nitrite itself 
might mediate biological effects (56). A variety of different nitrogen oxides can be 
formed in the acidic gastric milieu and elsewhere which can mediate NO-like signalling. 
Thiol groups (-SH) in cysteine residues of proteins might undergo S-nitrosation by nitrite, 
generating S-nitrosothiols which can act as NO donors (57) or generate post-translational 
modifications that can alter protein function (58). Other responses might be mediated by 
the generation of electrophilic nitro-fatty acids (NO2-FA). Nitration of unsaturated fatty 
acids can be induced by nitrite-derived nitrogen oxides (NOx), especially the nitrogen 
dioxide radical (·NO2), formed in high amounts during gastric acidification of nitrite (59). 
The electrophilic properties of nitrated fatty acids can mediate anti-inflammatory 
signalling through activation of nucleophilic proteins such as the peroxisome proliferator 
activated receptor-γ (PPAR-γ) and suppress inflammatory NF-kB signalling. Although 
endogenous formation of nitro-fatty acids occurs, the levels found in plasma are in a low 
range, and some authors have questioned if they play a role in normal physiology (60, 
61). 
1.4 Unsaturated fatty acids  
Fatty acids are an essential part of the inflammatory response, by modulating 
inflammatory processes and by acting as substrates for the generation of signalling 
molecules (62). Poly- or mono- unsaturated fatty acids (PUFA, MUFA) contain one or 
more double bonds in the carbon chain and ingestion of these compounds have been 
linked with health benefits (63). However, the effects are heavily dependent on the type 
of fatty acid ingested. The general consensus is that the typical western diet contains high 
amounts of n-6 PUFA and lover levels of n-3 PUFA, leading to an unbalanced fatty acid 
ratio, which is linked with many inflammatory diseases including obesity, rheumatoid 
arthritis and inflammatory bowel disease (IBD) (63, 64). The major n-6 PUFA from 
vegetable sources is linoleic acid (LA, 18:2n-6), which is a precursor for arachidonic acid 
(AA) that is subsequently converted into inflammatory eicosanoids, such as 
prostaglandins and leukotrienes. On the other hand, the major vegetable source of n-3 
PUFA is α-linoleic acid (ALA, 18:3n-3), which can modulate the inflammatory response 
by mediating competitive inhibition of the inflammatory eicosanoids (63-65). However, 
the role of PUFAs in mediating an overall pro- or anti-inflammatory effect is still unclear. 
Unsaturated fatty acids can also be nitrated by reactions with nitrogen oxide species as 
mentioned above. These reactions result in formation of for example nitro linoleic acid 
and nitro oleic acid, both of which have anti-inflammatory effects by inhibiting pro-
inflammatory cytokines (66).  
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1.4.1 Conjugated linoleic acid (CLA) 
Conjugated linoleic acids (CLA) are natural fatty acids found in egg, meat, cheese and 
other dairy products. It is a group of positional isomers of linoleic acid [18:2], which is 
typically present in plants (67). Up to twenty-eight different isomers are included in the 
CLA family, but the two most abundant isoforms of CLA found in foods and 
supplemental preparations are cis-9,trans-11 (c9t11) and trans-10,cis-12 (t10c12) (Fig. 
3). These two forms are considered to be bioactive (67). The two double bonds found in 
CLA are separated by one single bond, hence the term conjugated. From dietary sources, 
up to 90% of the total CLA intake consists of the c9t11 isoform (68), which is suggested 
to have regulatory effects of the immune response, while t10c12 is more involved in 
regulation of body fat mass (69, 70). CLA is formed in the rumen of ruminant animals as 
an intermediate product of complete bacterial biohydrogenation from linoleic acid to 
steric acid [18:0], thereby changing the double bonds into a saturated carbon chain (71) 
(Fig. 4). The rumen bacterial conversion was earlier assumed to be the major source of 
CLA isomers in dairy products. However, another intermediate in this process is trans-
vaccenic acid [18:1], a form of fatty acid that can be incorporated into tissues of the 
animal and be converted back to c9t11 by the enzyme delta-9 desaturase. This is now 
considered to be the major pathway of c9t11 formation, explaining the high levels of 
CLA found in milk and beef (72). The formation of c9t11 by delta-9 saturation has also 
been observed in humans and rodents (73). The mechanistic explanation for CLA-
mediated protection against inflammation is still largely unknown. However, there have 
been indications that CLA might enhance the production of the anti-inflammatory 
cytokine IL-10 in dendritic cells and in macrophages, which in turn reduces NF-kB 
activity (74, 75). Furthermore, macrophage activity seems to be influenced by CLA 
treatment by responding with a decreased production of proinflammatory cytokines and 
other inflammatory mediators such as COX-2 as well as inhibition of iNOS via a PPAR-γ 
mediated mechanism (76). The intake of CLA from natural sources has been estimated to 
be around 150 - 440 mg/day (67, 77, 78), a dose that is very low compared to dietary 
supplementation studies made with this fatty acid (70). When studying the health effects 
of CLA, supplementation is usually administrated by a mix of isomers c9t11 and t10c12 
in ratio 1:1, either as free fatty acids or as incorporated in phospholipids. At present, both 
the US Food and Drug administration and the European Food Safety Authority has 
approved a supplemental dose of 3g/day CLA, with an of intake up to 6 months (79). 
Due to the presence of double bonds in CLA, radical reactions are possible that might 
lead to the formation of nitrated fatty acids. In a recent study, CLA was even 
demonstrated to be a preferential substrate for endogenous nitration in favour of other 
fatty acids due to the specific location of the double bonds. Nitrated CLA has also been 
detected in tissues of mice supplemented with nitrite and CLA and in plasma of healthy 
humans (80).  
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Figure 3. Chemical structure of linoleic acid and the two most abundant isoforms of 
conjugated linoleic acid. 
 
Figure 4. Pathways for rumen and tissue synthesis of cis-9, trans-11 CLA and alteration 
in the biohydrogenation pathway of linoleic acid into synthesis of trans-10, cis-12 in the 
ruminant animal. Figure modified from (81). 
 
Over the past two decades, the intake of trans fatty acids (TFAs) have decreased 
significantly due to the reported increased risk of CVD (82). The group of TFAs is 
characterized by containing one or more double bond in trans configuration, and TFA can 
be divided into two different groups; artificial (industrial) and natural (ruminant) trans 
fatty acids. The industrial TFAs are formed from partly hydrogenated vegetable oils and 
can be included in foods in order to replace animal fats and to increase shelf life of the 
products (83). In spite of the negative view of trans fatty acids on human health, the 
naturally formed trans fatty acid CLA has been shown to reduce body weight, have 
effects against cancer and cardiovascular diseases and to modulate inflammatory 
responses in various animal models of disease (70). For that reason, all isoforms of CLA 
are excluded in the definition of TFA (79). However, the effects of CLA in humans are 
not always as conclusive as in animal models and the mechanisms of action are often 
unknown (67). A recent overview of clinical studies with natural TFA, shows that 
moderate intake does not increase the risk for cardiovascular diseases (79). To the 
contrary, there are also indications that the intake of CLA, especially as a supplement in 
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higher amounts, may have similar unfavourable effects on lipoprotein levels as other 
trans fatty acids (82). More safety studies on the intake of CLA in relation to other TFA 
are needed to delineate the difference in effect and mechanisms of actions.  
1.5 Gastrointestinal mucosal defence  
The mucosal membrane lining the gastrointestinal tract is an important barrier against 
external threats as well as endogenously secreted factors such as gastric acid and 
degrading digestive enzymes. Pathogens accompanying the intake of food and fluids or 
inhabiting the colon may cause damage to the host. The mucosa consists of a single layer 
of epithelial cells covering the basement membrane, the lamina propria and a thin layer of 
smooth muscle cells (Fig. 5). The entire mucosa of the gastrointestinal tract is covered by 
a secreted mucus layer, which in conjunction with a tight epithelium, resident immune 
cells and well-functioning mucosal blood flow protects the mucosa from damage.  
   
Figure 5. Schematic picture of the gastrointestinal mucosa and the luminal mucus layer.   
 
1.5.1 The gastrointestinal mucus layer 
The well-organized protective layer of mucus covering the surfaces of the gastrointestinal 
tract consists of secreted gel-forming mucins. These are highly glycosylated large 
glycoproteins originating from the MUC genes (84). In the small and large intestine, the 
major secretory mucin synthesized and secreted by intestinal goblet cells is Muc2 (85, 
86), while Muc5ac and Muc6 are the most important mucins forming the cross-linked 
mucus layer in the stomach (87). Both the colon and the stomach have a protecting mucus 
layer organized in a two layer system; the loosely adherent layer adjacent to the lumen, 
and the inner firmly adherent layer (Fig. 5). The latter is strongly adherent to the 
epithelium and cannot be easily removed, while the outer layer can be ablated by suction 
(88). The mucus barrier is not static, but results from the release of mucins by epithelial 
mucus-producing cells, as well as degradation by proteolytic enzymes which is involved 
in formation of the two layers (89). A range of hormonal, neural and inflammatory 
substances regulate mucus formation and release including NO, histamine, 
prostaglandins, cytokines, hydrogen chloride and acetylcholine (90).  
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There is a great diversity in the functional aspects of the different parts of the GI-tract, 
and the mucus layer also has location dependent roles. In the stomach, production of 
hydrochloric acid by the parietal cells is of importance for degradation of food but also to 
limit growth of pathogens. However, since this is associated with a very low gastric pH 
(pH 1-2 in fasting humans), the mucus layer has an important function in protecting the 
epithelial cells from damage by maintaining neutral pH at the epithelial cell surface 
through the formation of a pH-gradient (91). The colonic mucus layer is suggested to be a 
functional barrier against luminal bacteria, thereby limiting bacteria-triggered 
inflammation. An absent colonic mucus layer has been observed in Muc2
-/-
 mice (86), 
which are very sensitive to chemically induced colitis and are prone to develop 
spontaneous inflammation and cancer with increasing age (92, 93). Also, in different 
mouse models of colitis and in patients with inflammatory bowel disease, the colonic 
mucus layer has been reported to be more permeable (94), thereby increasing the risk of 
bacterial translocation and subsequent inflammation. This suggests that the colonic mucus 
layer is essential to maintain colonic homeostasis and protect against acute and chronic 
inflammatory disease. 
1.5.2 The epithelial cell barrier  
An intact epithelial barrier is essential for the integrity of the gastrointestinal mucosa. 
Insults to the epithelial cells, such as bacterial penetration, might result in an 
inflammatory response via rapid expression and secretion of pro-inflammatory cytokines 
and chemoattractants. Resident immune cells together with the epithelium thereby alert 
the innate immune system to the presence of foreign substances which provide signals for 
the onset of further inflammatory responses (95). Minor disruptions of the surface layer 
are frequent due to friction by the large amounts of materials passing through, as well as 
the acidic environment and degrading enzymes present. More severe injuries as a result of 
illness or pharmacological side effects might also occur. Both smaller and more serious 
damage to the epithelial cell layer require rapid repair, starting with restitution followed 
by regeneration. Restitution is the spread of epithelial cells over the basement membrane 
to restore the cell-cell contact in order to prevent bacteria or harmful antigens from 
infiltrating the underlying compartments. This process is mediated by many factors, 
however trefoil factors (TFFs) have attained increased attention in recent years and are 
suggested to play a key role in epithelial restitution (96, 97). Three isoforms of trefoil 
factors have been identified; gastric peptide (pS2/TFF1), spasmolytic peptide (SP/TFF2) 
and the intestinal trefoil factor (ITF/TFF3). The two former are produced in the gastric 
and duodenal mucosa (98-100) while TFF3 is localized to the small and large intestine 
and produced by the goblet cells and excreted with mucins (101). All TFFs have 
conserved motifs of 6 cysteine residues called the “trefoil” domain; resulting in inter-
disulfide bonds that mediate a compact structure which probably mediates the resistance 
to protease degradation (97). Many studies have demonstrated the important effect of 
these peptides in gastrointestinal mucosal homeostasis (102, 103), which are suggested to 
stabilize the mucus structure and are also highly involved in wound healing (97, 104-
106). Specific deletion of the TFF3 gene in mice increased the susceptibility to colonic 
injury in various experimental models of colitis (107), which could be reversed by 
additional administration of TFF3 (104).  
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Another important protein in gastrointestinal epithelial cells is the nuclear receptor 
PPAR-γ, which is one of three members in the PPAR subfamily. These are conserved 
ligand activated transcription factors, stimulated by small hydrophobic signalling 
molecules such as hormones, steroids and fatty acids. Upon ligand binding, the receptor 
can regulate gene expression by activation or repression (108). PPAR-γ is highly involved 
in metabolic regulation, participating in energy storage and glucose homeostasis. 
Expression of PPAR-γ is high in colonic epithelium and in activated immune cells (61, 
109), and is suggested to also be an important mediator in several anti-inflammatory 
pathways. Activation of PPAR-γ has been shown to alleviate inflammation in various 
disease models including experimental models of colitis (61). PUFAs are known ligands 
for PPAR-γ (110), which can reduce expression of NF-kB (61) by a suggested 
suppression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) (111). Nitrated fatty 
acids are also candidates ligands to PPAR-γ (112), and supplementation with nitrated 
oleic acid has been proven to be protective in an experimental model of colitis (113). 
CLA isomers are other proposed activators of PPAR-γ, and have also been demonstrated 
to alleviate inflammation in experimental colitis (114-116). The presence of a PPAR-γ-
binding site in the TFF2 gene has been proposed, which may mediate the anti-
inflammatory effects of CLA (117). A similar binding site might exist on the TFF3 gene 
and therefore mediate protective effects. However, little is known about the effects of 
PPAR-γ ligands and the regulation on TFF3 genes in colitis.  
1.5.3 The inflammatory response  
The immune system has an essential role in the defence against pathogens, protecting us 
from severe infections. In general, the immune system is divided into cells active in the 
innate or the adaptive system with different cells and signalling cascades. The acute 
inflammatory response is initiated by a rapid recruitment of leukocytes from the blood to 
the afflicted site, primarily involving neutrophils which are a part of the innate immune 
system. In humans, ~60% of all circulating leukocytes are granulocytic neutrophils, 
compared to only ~10% in mice (118). These short-lived immune cells are a vital part of 
our immune system. In the intestinal vasculature and in other microvascular beds in the 
body, the endothelium regulates the entry of leukocytes in a multi-step mechanism (Fig. 
6). The recruitment cascade is initiated by upregulation of selectins on the activated 
endothelium, e.g. P-selectin, which induces leukocyte rolling along the blood vessel wall. 
Next, leukocyte binding of chemokines presented on the endothelium induces integrins 
on the surface of the leukocytes and mediate adhesion, crawling and finally 
transmigration through of the vessel wall. The transmigration of leukocytes involves 
complex binding of endothelial ligands, where a key adhesion molecule is the 
intracellular adhesion molecule type 1 (ICAM-1). Subsequently, leukocyte binding to 
components in the endothelial junction and the perivascular basement membrane further 
progresses the transmigration (119-123). The direction of leukocyte movement in this 
process of crawling and transmigration is governed by an intravascular chemokine 
gradient originating from the afflicted tissue (124). Accumulation of infiltrated leukocytes 
is a key feature in IBD, and an abnormal microvascular leukocyte recruitment might lead 
to impaired mucosal healing and chronic inflammation (95).  
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Figure 6. Schematic illustration of the leukocyte recruitment cascade in acute 
inflammation. 
1.6 Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory illness of the 
gastrointestinal tract, comprising mainly Ulcerative Colitis (UC) and Crohn´s disease 
(CD). These diseases are thought to be due to a dysregulated immune response to the 
commensal microflora, which has a genetic link and can be developed by environmental 
triggers (95). CD is generally displayed by an irregular, transmural inflammation, most 
commonly observed in the ileum and colon, but can affect any part of the GI-tract. UC on 
the other hand is usually affecting the colon and rectum in a more continuous pattern, and 
the inflammation is typically limited to the mucosa (95, 125). The pathogenesis of the 
disease is not fully understood but the incidence of both UC and CD has steadily 
increased in the western countries since the mid-1900s (126). The highest prevalence of 
IBD is reported in Europe and North America (127) and approximately 0.5-1% of the 
Swedish population is affected (128). There has also been an increase in the incidence 
and prevalence of IBD during the past decade in Asia, particularly in East Asia (129) 
(Fig. 7). The reason for the increased incidence is not entirely clear, but diet and lifestyle 
factors, which have dramatically shifted over the last decades, have been discussed (126). 
The interactions between the host and the intestinal microbiota are in many cases 
beneficial in modulating the immune system, regulating energy metabolism and in 
extracting important nutrients (130). However, interactions with bacteria can also be 
deleterious to the host by disrupting the mucosal barrier and initiating an uncontrolled 
inflammatory response which might lead to the development of IBD (131). As mentioned 
above, an altered mucus layer has been demonstrated in patients with UC with indications 
of bacterial penetration of the inner mucus layer (94, 132). Bacterial penetration can lead 
to infiltration of immune cells and cause destruction of the protective epithelial cell layer. 
Injuries of the epithelial cell layer are a prominent feature in UC and this damage is 
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resembled in some animal models of inflammation including DSS-induced colitis 
(dextran sulfate sodium, see below) (133, 134). Hence, stimulation of mucosal healing is 
an important target in modern therapeutic strategies for UC and a key end-point in many 
clinical trials today (133). By obtaining mucosal healing, the long-term development of 
the disease appears to be improved (135).   
 
Figure 7. Worldwide annual incidence of inflammatory bowel disease. Red refers to 
incidence greater than 10 per 100,000, orange to incidence of 5–10 per 100,000, green to 
incidence less than 4 per 100,000 and yellow to low incidence that is continuously 
increasing. Figure adapted from (136). 
 
UC is a life-long disease with a relapsing nature, which adversely affects the quality of 
life (125). No curative treatment exists for these patients today. Instead, the therapy aims 
to induce remission by anti-inflammatory and immunosuppressive drugs. However, most 
of these have serious side-effects in long-term management of the disease, often due to 
the immunosuppression (137). More recent therapeutic approaches under development 
are focusing on inhibiting specific proinflammatory cytokines, thereby preventing 
immune cell activation and proliferation (95). However, approved biological therapies 
available today are limited to antibodies directed towards tumour necrosis factor alpha 
(TNFα), and a large part of patients are non-responders (138). Furthermore, in patients 
with more severe relapses and with poor effects of medical treatment, surgery is often the 
only option (125). The development of new treatments and nutritional strategies to better 
control the disease is important, in combination with further research to understand the 
disease mechanisms.  
1.6.1 Experimental models of colitis  
At present, there are over 50 mouse models of intestinal inflammation, often divided into 
acute or chronic models of colitis. Oral administration of DSS is the most common acute 
animal model of IBD, particularly in mice (139). The mechanism of DSS-induced colonic 
injury is still largely unknown. However, the acute inflammatory reactions are believed to 
occur by non-specific damage to the colonic epithelium and heavily depend on the use of 
mouse strain and the molecular weight of the DSS (140, 141). Typical symptoms in 
animals are weight loss, bloody stools and diarrhoea (134), in combination with common 
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histological features such as epithelial ulceration, loss of goblet cells and infiltration of 
immune cells (142, 143). These pathophysiological characteristics resemble injuries that 
can be observed in human UC (134, 142). In many other aspects, this model is considered 
to be a relatively poor surrogate for the human disease, i.e. in complexity of the 
inflammatory response. The pathology of DSS mainly involves the innate immune system 
with increased infiltration of macrophages and polymorphonuclear leukocytes (PMNs), 
with little contribution from the adaptive system of T- and B-cells (144). Nevertheless, 
since DSS is thought to have direct toxic effects on epithelial cells in combination with 
immune cell infiltration, the DSS-model is suggested to be quite useful in studies of 
mucosal wound repair (139).  
                                                                                                                                 Aims 
 
15 
 
2 AIMS 
 
The overall aim of this thesis was to study the metabolism of dietary nitrate, nitrite and 
conjugated linoleic acid (CLA) and their effects on inflammatory processes. The more 
specific objectives of this thesis were: 
 
Paper I:  To investigate the effects of nitrite and dietary nitrate on leukocyte 
recruitment in microvascular inflammation and in NSAID-induced 
intestinal injury. 
 
Paper II:  To examine the anti-inflammatory effects of CLA in DSS-induced colitis 
and the involvement of PPAR- γ and TFF3 activation. 
 
Paper III:  To investigate the preventive and therapeutic effects of dietary nitrate and 
nitrite in DSS-induced colitis and the regulation of colonic mucosal 
integrity. 
 
Paper IV: To determine the involvement of the oral microflora and nitrite in 
physiologic regulation of gastric mucus formation.  
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3 MATERIALS AND METHODS 
Brief descriptions of the methods used in this thesis are described below. For more 
detailed information, please see the material and methods section for each specific paper.  
3.1 Experimental animals 
The following strains of mice were used in these studies; male C57/Bl6 (B&K Universal, 
Stockholm, Sweden and Taconic M&B, Ejby, Denmark), female BALB/c (Scanbur AB, 
Sollentuna, Sweden), male NMRI (Scanbur AB, Sollentuna, Sweden) and male germ free 
NMRI mice (germ free animal facility, Karolinska Institutet, Sweden). All mice weighed 
18-45 g and were housed under standardized conditions of temperature (21-22°C), 
humidity and illumination (12-h light/darkness). Male Sprague-Dawley rats (Charles 
River, Scanbur AB, Sweden), weighed 210-310g and were kept under the same standard 
conditions as the mice. All animals were allowed to adjust to the cage environment at 
least 7 days before experimental start with free access to pellet food and tap water. All 
experiments were approved by the Ethics Committee for Animal Experiments at the 
Karolinska Institute and Uppsala University.  
3.2 Animal treatments  
3.2.1 Nitrate supplementation (Paper I, III, IV) 
In the animal experiments of paper I, III and IV, mice and rats were given sodium nitrate 
(10 mM; Sigma-Aldrich) in the drinking water for 7 days before start of experiments. 
This concentration of sodium nitrate resulted in a daily intake of around 140 mg/kg
 
body 
weight for mice and 85 mg/kg body weight for rats.  
3.2.2 Nitrite administration (Paper I, III, IV) 
In paper I, sodium nitrite (1.3 mg/kg; Sigma-Aldrich) was injected i.v. to mice in a bolus 
dose (0.1 ml) through a cannulated jugular vein. In paper III, mice were administrated 
sodium nitrite (1 mM) in the drinking water for 7 or 4 days, resulting in a daily intake of 
10 mg/kg body weight. Conventional and germ free mice in paper IV, were supplemented 
with sodium nitrite (1mM, 0.25mM or 50µM) in the drinking water for 7 days, mediating 
a daily intake of about 11 mg/kg, 2.75 mg/kg or 0.55 mg/kg body weight, respectively.   
3.2.3 CLA supplementation (Paper II) 
Mice in paper II were supplemented with CLA (50:50 cis-9,trans-11 and trans-10,cis-12, 
purity >99%; Nu-Chek Prep) in their chow to obtain a daily intake of 100 mg/kg. 
3.2.4 Induction of gastrointestinal NSAID-injury (Paper I) 
NSAID-induced small intestinal injury was induced in paper I. Mice were administrated 
diclofenac (60 mg/kg) via gavage after having fasted 6 h before and 3 h after 
administration. N
G
-nitro-L-arginine methyl ester (L-NAME, 1g/L; Sigma–Aldrich) was 
added to the drinking water 24 h before diclofenac gavage, and given as an additional 
bolus dose (10 mg/kg) with the diclofenac. Examination of the intestines was performed 
17-19 h later. In separate experiments, rats were gavaged with diclofenac (30 mg/kg) after 
being fasted 4 h before and investigated 17-19 h later.  
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3.2.5 Chlorhexidine mouth spray (Paper I) 
In the rat experiments of paper I, the oral microflora was suppressed in some animals. 
Rats were treated twice daily with 0.3 ml chlorhexidine mouth spray (2 mg/ml, 
CorsodylR, GlaxoSmith-Kline) applied topically onto the dorsal part of the tongue for a 
period of 7 days with or without nitrate supplementation.  
3.2.6 Induction of experimental colitis (Paper II, III) 
Experimental colitis was induced in female BALB/c mice in paper II and III. DSS (2 or 
2.5%, 45 kDa; TdB Consultancy, Uppsala, Sweden) was added in the drinking water for 7 
days. To evaluate the severity of the disease the Disease Activity Index (DAI) was 
assessed daily. The score is based on three parameters; the degree of body weight loss, 
diarrhoea and faecal haemorrhage, earlier described by Ito et al (145). On day 7, mice 
were sacrificed by cervical dislocation under induced anaesthesia with isoflurane (Abbot, 
Scandinavia, Sweden). The presence of blood in stools was evaluated by analysis of 
Hemoccult (Beckman Coulter), the colon length was measured and plasma and other 
tissues were snap frozen and kept in -80°C until further analysis. 
3.2.7 Antibiotic treatment of mice (Paper IV) 
To obtain a clinically relevant model of microflora elimination, mice were treated with 
broad spectrum antibiotics in paper IV. An antibiotic cocktail consisting of ampicillin (1 
g/L, Sigma), vancomycin (500 mg/L, Hospira), neomycin sulfate (1 g/L, Gibco), and 
metronidazole (1 g/L, Braun) was added to the drinking water for four weeks prior to 
further experiments. The antibiotic cocktail was replaced with a freshly made solution 
every 2-3 days. The method has been used earlier for depletion of gut microbiota (146). 
Bacteria from colonic faeces (aerobic and anaerobic) and bacteria scraped from the oral 
cavity (aerobic) were cultivated for 72 h and inspected for growth. The nitrate reducing 
activity of oral bacteria on the plates was investigated. Colonies were grown over night in 
Mueller Hinton broth and separate incubations were made with 1 mM sodium nitrate 
(Sigma-Aldrich) for 0, 1, 2, 3, 4, 5 and 6 h. The reaction was stopped by adding methanol 
(1:2) and freezing at 20°C until analysis. The incubated samples were centrifuged and the 
nitrate and nitrite concentrations were measured using the highly sensitive HPLC method 
(ENO-20; Eicom Japan).  
3.3 In vivo animal protocols 
3.3.1 Leukocyte recruitment in microvascular inflammation (Paper I) 
Leukocyte recruitment in microvascular inflammation was explored through intravital 
microscopy in paper I (Fig. 8). Mice were anesthetized by spontaneous inhalation of 
isoflurane (Abbot, Scandinavia, Sweden) and the left cremaster muscle was gently 
opened and mounted for observation of leukocytes in postcapillary venules through 
bright-field intravital microscopy (Leitz Ortholux II with 25x/0.6W objective, connected 
to a Hamamatsu C3077 camera). Throughout the experiment, the muscle was constantly 
kept moisture by superfusion of bicarbonate-buffered saline (pH 7.4, 37°C).  Induction of 
neutrophil recruitment in the cremaster muscle was made by adding murine macrophage 
inflammatory protein 2 (MIP-2, CXCL2; R&D Systems, England) to the buffer. The 
MIP-2 superfusion (0.5 nM) continued for 90 min. A 5-min base line recording of chosen 
vessel was done before the MIP-2 superfusion and further recordings were made at 30, 60 
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and 90 min at the same spot. In separate experiments, the sGC inhibitor 1H-
[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ; Tocris Bioscience, USA) was added to 
the buffer (100 µM) to investigate potential NO-sGC-cGMP aspects of leukocyte 
recruitment. Neutrophils were analysed in the recordings for number of rolling cells 
(number of leukocytes passing per min), rolling velocity (average time of 10 first cells 
passing over a 100 µm segment), adhesion (cells stationary for more than 30 s) and 
emigration (cells in the extravascular space within the field of view 0.05 mm
2
). 
 
Figure 8. Left: The experimental set-up of the cremaster muscle for in vivo imaging of 
leukocyte recruitment in microvascular inflammation. Pre-warmed bicarbonate-saline 
was superfused over the muscle to keep it moist and MIP-2 and ODQ was added to the 
buffer. Right: 5 min recordings of the selected postcapillaty venule were made before and 
at time 30, 60 and 90 min of MIP-2 superfusion and later analysed for number of rolling, 
adherent and emigrated leukocytes.  
3.3.2 Blood flow measurements (Paper I, IV) 
To measure organ blood flow in the small intestine of rats in paper I, a microsphere 
technique was used. Rats were anesthetized by an intraperitoneal injection of inactin 
(thiobutabarbital sodium 120 mg/kg; Research Biochemicals, USA) and catheters were 
inserted in the femoral and carotid artery. During the entire experiment, the blood 
pressure was monitored. When arterial blood pressure was stable, the diluted 
nonradioactive microspheres (~300 000, 15µm in diameter) (E-Z Trac Ultraspheres; IMT, 
Stason Laboratories, USA) were injected through the carotid catheter over 10 s. A 
reference blood sample was withdrawn from the femoral catheter with a constant rate 
(~0.55ml min
-1
) staring 10 s before injection of microspheres until 60 s after injection. To 
evaluate the organ blood flow in the small intestine the rats were sacrificed by an i.v. 
injection of potassium chloride and pieces of the ileum and kidneys was quickly removed 
and weighed (~150 mg and ~100 mg respectively). The microspheres were visualized 
using a method of freeze-thawing and counted in the organs and reference blood sample 
using a light microscope. Organ blood flow in the ileum was calculated according to the 
following formula; Qorg= (Norg×Qref)/Nref. Qorg is the organ blood flow (ml/min x g 
tissue), Qref is the blood flow in the reference sample (ml/min), Norg and Nref are the total 
numbers of microspheres present in the organ or the reference sample, respectively. The 
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microspheres counted in the kidneys and the following obtained value of blood flow were 
used as to assure adequate mixing of the microspheres in the circulation. A difference of 
less than 10% in the blood flow values between the two kidneys was accepted as 
sufficient mixing.   
In paper IV, blood flow in the exposed gastric mucosa of mice was measured using 
Laser-Doppler flowmetry (PeriFlux 4001 Master and PeriFlux Pf 3; Perimed, Stockholm, 
Sweden).  With this method, the number and velocity of the red blood cells are measured 
by a laser light (wavelength 635 nm, helium neonlaser). The reflected light is recorded by 
a pair of fibers and the velocity is calculated as the change in frequency, namely the 
Doppler shift. The gastric mucosa in conventional and germ free mice were treated with 
topical administration of sodium nitrite (1mM, pH 3; Sigma-Aldrich) and the laser probe 
was fixed by a micromanipulator and placed at the same spot above the mucosa (0.5-1 
mm) to monitor the gastric blood flow.  
3.3.3 Bacterial clearance (Paper I) 
In the investigation of bacterial clearance in paper I, bioluminescent S. aureus (strain 
Xen29, Caliper Life Sciences, USA) was injected subcutaneously in the back of mice. 
Before injection (~24h), a part of the back fur was removed with a depilatory cream. 
Bacteria were cultured to exponential growth level, as measured by a spectrophotometer 
and were diluted with a carrier of saline Cytodex beads (10mg/ml) (Sigma–Aldrich) in 
PBS. Approximately 1 × 10
6
 CFU (colony-forming units) was injected into isoflurane 
anesthetized mice, with or without pretreatment of nitrate. Bacterial clearance was 
monitored by a Xenogen bioimaging device (IVIS Spectrum; Caliper Life Sciences) in 
mice under anaesthesia by isoflurane at 0, 0.75, 2.5, 5, 12 and 24 h and thereafter every 
24 h postinoculation for 14 days. Bioluminescence was quantified using Living Image 
software (Caliper Life Sciences).  
3.3.4 Quantification of P-selectin expression (Paper I) 
Measurements of P-selectin expression in the small intestine of rats were performed in 
paper I, in order to evaluate the acute intestinal inflammation. Rats were anesthetized 
with inactin (thiobutabarbital sodium 120 mg/kg; Research Biochemicals, USA) and a 
dual-labelled monoclonal antibody technique was used, previously described in detail 
(147). In brief, catheters were inserted in the left jugular vein and right carotid artery for 
injection of antibodies and blood sampling, respectively. A mixture of 10 µg of 
125
I -
labelled P-selectin MAb (RMP-1) and 5 µg of 
131
I-labeled nonbinding MAb (P-23) was 
injected. Blood samples were subsequently taken via the carotid artery in preheparinized 
rats (3,000 IU/kg), after 2.5 and 5.0 min. The animals were then drained of blood and the 
small intestine was collected and weighed. Quantification of P-selectin expression was 
determined by analysing the activity of the 
125
I and 
131
I antibodies in the small intestine 
using an LKB 1282 Compugamma (Wallac Oy, Turku, Finland).  
3.3.5 Gastrointestinal mucus thickness measurements (Paper III, IV)  
Colonic mucus thickness was examined in the DSS-induced colitis and nitrite pretreated 
mice in paper III. In paper IV, gastric mucus thickness was measured in conventional or 
germ free mice. The general surgery set-up and method of mucus thickness measurements 
is illustrated in Figure 9. Mice were anesthetized with spontaneous inhalation of 
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isoflurane (Abbot, Scandinavia, Sweden) through a breathing mask and the body 
temperature was maintained at 37°C by a heating pad underneath the mouse. Preparation 
of the mice was done by opening the abdomen through a midline incision. The distal 
colon was exposed and opened longitudinally by cautery, while the stomach was opened 
along the greater curvature of the forestomach, following loosening of ligaments. Both 
the colon and stomach were draped over a truncated cone with the mucosal side facing 
up. The mucosa was then exposed through a hole in a mucosal chamber (0.2 cm
2
) that 
was placed over the tissue and sealed with silicon grease. To maintain the moistness of 
the mucosa, the chamber was filled with 37°C 0.9% saline solution. In some of the gastric 
mucus measurements, the chamber was filled with acidic saline (pH 2) and sodium nitrite 
(1mM) for 60 min before mucus measurements. Also, ODQ (Sigma-Aldrich) was added 
to the solution (1mM) dissolved in 5% DMSO in some experiments.   
The mice were left to stabilize for 30-60 min after the surgery before measurements of the 
mucus thickness. Glass micropipettes were pulled to obtain a thin tip (1-3µm) and dipped 
in silicon solution for a non-adhesive surface and to avoid mucus from adhering to the 
glass. To visualize the luminal mucus layer, a suspension with charcoal particles was 
applied on the mucosa. The micropipette was connected to a micromanipulator (Leitz, 
Wetzlar, Germany) and pushed into the mucus gel at an angle (a) of 30-40° to the 
epithelial cell surface. The distance from the mucus surface to the epithelial cells (b) was 
measured with a digimatic indicator and the thickness of the mucus gel (T) was then 
calculated (Fig. 9). The technique has been described in detail previously (148). To 
measure the firmly adherent mucus layer, the outer loosely adherent layer was gently 
removed by suction with a thin cannula connected to a syringe. The mean value of mucus 
measurements at five different spots was used as one observation to obtain a more true 
value of the mucus thickness.  The same five spots were measured again after 1h to reveal 
mucus dynamics.  
 
 
Figure 9. Left and middle: Mouse preparation for mucus thickness measurement. Right: 
A schematic drawing describing the mucus measurement and the values obtained for 
mucus thickness calculations. 
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3.4 In vitro methods  
3.4.1 Cell cultures and wound repair assay (Paper I, II, III) 
In paper I, human dermal microvascular endothelial cells (HDMEC) were used to study 
surface adhesion molecules with immunofluorescence. Human colon epithelial cells 
(SW480) were cultured for experiments in paper II and III for investigating gene 
expression by qPCR of PPAR-γ and TFF3, and to study the effect of nitrite in wound 
healing. The wound healing assay has previously been described in detail (149). For more 
detailed information about cell culture conditions and treatments, see the material and 
methods section for each specific paper.   
3.4.2 Immunohistochemistry and histology (Paper I, II, III)  
Fluorescent immunohistochemistry was performed in paper I of cultured HDMEC. Cells 
were stained with mouse anti-human ICAM-1 (10 μg/ml; R&D Systems) and secondary 
fluorescent antibody goat anti-mouse Alexa 555 antibody for ICAM-1(1:500; Invitrogen, 
Eugene, OR, USA) after treatment with TNF-α and sodium nitrite. Visualization and 
detection were made by a confocal microscope and the ICAM-1 intensity was quantified 
using ImageJ (1.43u; National Institutes of Health, USA).  
Immunohistochemistry of frozen colonic tissue from mice treated with DSS and 
additional treatments of nitrate, nitrite or CLA was performed in paper II and III. 
Following excision of the colon, specimens from the proximal and distal part of the colon 
were placed in TissueTec (Oct Cryomount, Histolab, Sweden), snap frozen and kept in -
80°C. Cross sections of colon tissue (6 μm) were fixed in 1% paraformaldehyde (Sigma-
Aldrich) for 10 min and washed with PBS. Blocking of endogenous peroxidases with 
H2O2 (Sigma-Aldrich) was done for 10 min followed by PBS washing and applying the 
avidin-biotin system (Vector Laboratories, USA) for reducing the non-specific 
background, 15 min each. The specimens were incubated with primary antibody (see 
specific antibodies in each specific paper) over night at +4°C. Further blocking of non-
specific binding with bovine serum albumin (Sigma-Aldrich) for 1 h prevented the 
secondary antibody from cross reacting with endogenous immunoglobulins in the tissue. 
Incubation with secondary biotin-conjugated antibody (Jackson Immuno Research, USA) 
was done for 30 min followed by applying the avidin biotinylated enzyme complex 
(Vectastain ABC kit, Vector Laboratories, USA) and 3,3- diaminobenzidine (DAB; 
Vector Laboratories, USA) was used to detect the antibody. Sections were counterstained 
with hematoxylin (Sigma-Aldrich) for visualization of tissue structure. The expression 
score of each protein was expressed using a graded scale from 0-3, reflecting the intensity 
of staining, judged by a researcher blinded to the protocol.   
Histological analysis of colonic tissue from DSS-treated mice was performed in paper III 
to investigate tissue morphology and inflammatory status. Intact mice colons were 
embedded in paraffin and cut in longitudinal sections (4 μm). Staining with hematoxylin 
and eosin (H&E) was done to analyse inflammatory status and tissue destruction, and 
alcian blue–periodic acid-Schiff (PAS) staining was done to visualize colonic mucin. 
Disease severity and abundance of goblet cells (mucin) was evaluated by a score of 0-3 
by a researcher blinded to the section protocol.  
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3.4.3 mRNA isolation and qRT-PCR (Paper II, IV) 
Total mRNA was isolated from colonic epithelial cells or snap-frozen stomach tissue by 
homogenization in Trizol reagent in paper II and IV, respectively. The relative gene 
expression levels of PPAR-γ, TFF3, HO-1, Muc5AC and Muc6 were determined by real-
time PCR using ABI 7500 Fast Real-Time PCR system (Applied Biosystem, Sweden) 
and β-actin was used as standard control. Amplification was carried out by SYBR Green 
PCR Master Mix (Applied Biosystem, Sweden). See information about primer sequences 
and thermal conditions in the methods section for each specific paper.   
3.4.4 Intestinal neutrophil infiltration (Paper I) 
To study neutrophil infiltration in intestinal tissue from mice treated with diclofenac and 
nitrate, a quantitative measure of myeloperoxidase (MPO) was performed with enzyme 
linked immunosorbent assay (ELISA). See specific details about the protocol in the 
methods section for paper I.   
3.4.5 Nitrate, nitrite and RXNO measurements in plasma (Paper I) 
Plasma levels of nitrate, nitrite and RXNO were measured from mice directly after i.v. 
injection of sodium nitrite (1.3 mg/kg) in paper I. Blood samples were collected and 
mixed with 100 mM N-ethylmaleimide/40 mM EDTA solution to prevent degradation of 
anions. The samples were immediately centrifuged (6500 rpm) for 5 min at 4 °C and 
stored at −80 °C until analyzed. Nitrite, nitrate, and S-nitrosothiols were measured by 
highly sensitive chemiluminescence (77 AM; EcoPhysics, Duernten, Switzerland) and 
HPLC methods (ENO-20; Eicom Japan). The method has been described in detail 
previously (26). 
3.5 Statistical analysis 
Single comparisons between two parameters were evaluated by a two-tailed paired 
Student’s t-test, were the animals served as their own control. Unpaired two-tailed 
Student’s t-test was used to compare values between two groups. For multiple 
comparations, significance was evaluated by analysis of variance with one-way ANOVA 
with the Tukey’s post hoc test. For changes within groups, repeated-measures ANOVA 
with Dunnett’s or Bonferroni’s multiple comparison test was used. Statistical analyses 
were performed with GraphPad Prism software 4.0 or 5.0 (GraphRad Software, La Jolla, 
CA, USA). All data are shown as means ± standard error of the mean (SEM). Values of P 
< 0.05 were considered significant.  
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4 RESULTS AND DISCUSSION 
With the discovery that nitrate and nitrite are not solely inactive NOS-derived end-
products of NO metabolism, but also constitute a reservoir for NO in blood and tissues 
(26), an extensive search for the role of these anions in health and disease has begun. 
Since NO has a fundamental role in blood flow regulation, many of the studies have 
focused on cardiovascular effects of inorganic nitrate and nitrite. These include protective 
effects in ischemia reperfusion injury (42), lowering of blood pressure (43), reversal of 
endothelial dysfunction and  inhibition of platelet aggregation (44). During recent years, 
an interest also in anti-inflammatory effects has emerged since NO has well-known 
effects in reducing leukocyte activation and adhesion (50, 51). Fatty acids are also 
involved in the regulation of inflammation. However, there are great variations in the 
action of these substances depending on structure and interaction with other signalling 
proteins (64). CLA is one particular fatty acid that has received increased attention in 
recent years due to its ability to modulate inflammatory reactions (67).   
This thesis investigates both systemic and local anti-inflammatory effects of different 
components of our everyday diet; nitrate, nitrite and CLA using different in vivo models 
enabling studies of immune cell behaviour and mucosal defence mechanisms of the GI-
tract. 
4.1 Paper I 
Decreased leukocyte recruitment by inorganic nitrate and nitrite in microvascular 
inflammation and NSAID-induced intestinal injury 
Recruitment of immune cells from the circulation to tissues is fundamental for host 
defence against pathogens, but accumulation of leukocytes can also lead to tissue damage 
and chronic inflammation when dysregulated. If the functional balance between pro- and 
anti-inflammatory mediators is lost, e.g. with low or too high NO-levels, the interaction 
of neutrophil and endothelium might result in a change to a pro-inflammatory state.  Such 
changes could contribute to many widespread chronic diseases in the Western world, 
including atherosclerosis and inflammatory bowel disease. These common disorders are 
associated with sustained low-grade inflammation, which results in aggravation of the 
disease (95, 150). Furthermore, neutrophil recruitment to adipose tissue during increased 
energy intake has also recently been indicated to play an important role in tissue 
inflammation and in the development of insulin resistance (151). Another large clinical 
problem involving upregulated inflammatory reactions is the adverse effects of various 
commonly used drugs. An example is the adverse effects from the widespread use of 
NSAIDs, inducing gastrointestinal injury (152). The initial mechanism of mucosal 
damage in response to NSAIDs is believed to be the result of increased leukocyte 
activation and adhesion prior to activation of the adaptive immune cells (153). With the 
notion that the immune response is a fundamental biological function, the question is how 
to manipulate these interactions without creating severe immunosuppressive 
consequences for the individual. NO has previously been shown to reduce leukocyte 
activity and adhesion (50, 51), and nitrite has been indicated to have similar results (53). 
In this study, we investigated if dietary nitrate affects leukocyte recruitment and in 
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addition, whether the ability to eliminate bacterial infection is affected by nitrate 
treatment. We also aimed to further elucidate the underlying mechanisms. 
4.1.1 Acute nitrite treatment attenuates leukocyte recruitment 
The effect of an intravenous injection of sodium nitrite on leukocyte behaviour during 
MIP-2-induced acute inflammation was investigated in the mouse cremaster muscle by 
intravital microscopy. A bolus dose of nitrite (1.3 mg/kg ) given before initiation of MIP-
2 superfusion, decreased neutrophil adhesion and emigration by 50-70% after 60 and 90 
min compared to control mice. This dose of nitrite has previously been demonstrated to 
have protective effects in a sepsis-induced model (154), and was chosen as an initial dose 
to see if effects on leukocyte recruitment could be observed. Another recent study has 
indicated decreased leukocyte recruitment by a similar single high dose of nitrite by 
intramuscular injection in an acute lung injury model induced by chlorine toxicity (155). 
In line with this study, our results suggest that nitrite can mediate a rapid protective effect 
against an acute inflammatory response by reducing infiltration of leukocytes. Also lower 
doses of nitrite administered in the drinking water for 3 weeks have earlier been shown to 
decrease leukocyte adhesion and emigration in a model of microvascular inflammation 
induced by high cholesterol diet (53). The reduced recruitment of neutrophils in response 
to MIP-2 in our study are most likely not due to lower amount of circulating leukocytes 
or altered blood flow, since neither rolling flux (cells/min) or rolling velocity (µm/s) was 
affected by the nitrite treatment. In accordance with this, Stokes and colleagues (53) 
observed no difference in leukocyte count, wall shear stress or blood pressure in oral 
long-term administration of nitrite. Also, Ahluwalia and colleagues (52) have previously 
shown that there are no differences in erythrocyte velocity or shear stress in mesenteric 
postcapillary venules of eNOS-/- mice, or in mice receiving the sGC inhibitor ODQ or an 
NO-donor in the superfusate. Instead, the reduced recruitment might, at least partly, be a 
result of a nitrite-dependent modulation of vascular adhesion molecules. Indeed, we noted 
that in TNF-α stimulated endothelial cells, the expression of ICAM-1 was downregulated 
in the presence of nitrite (100 µM). When investigating the mechanistic effects of nitrite-
mediated reduction in leukocyte recruitment during acute inflammation, ODQ was added 
to the MIP-2 superfusion buffer in order to explore if the effect was cGMP dependent. 
While ODQ did not affect nitrite-dependent reduction in neutrophil emigration, 
neutrophil adhesion was partly inhibited compared to what was observed in mice treated 
with only nitrite. This suggests that nitrite may interfere with the two different steps in the 
recruitment cascade via different signalling pathways. Besides feeding the established 
sGC-cGMP pathway via NO formation, nitrite may also signal by other mechanisms, for 
example by S-nitrosation of proteins. However, since the effect of ODQ on adhesion was 
apparent only at the last measurement of superfusion, continued measurements might 
have resulted in a more clear effect. It is also possible that ODQ did not block all sGC 
enzymes by 90 min, since this preparation in whole muscle can create a diffusion barrier. 
For the very same reason, a somewhat high concentration of ODQ was chosen compared 
to an earlier study of intravital microscopy in the mesentery (52).  
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4.1.2 Dietary nitrate decreases leukocyte emigration and reduces NSAID-induced 
injury 
Since it had become apparent that dietary nitrate could have NO-like effects in various 
physiological situations (43, 49, 55), we further investigated whether a dietary approach 
with nitrate could have similar effects as seen with nitrite. A dose of nitrate that 
resembles a high intake of nitrate-containing vegetables was given via the drinking water 
one week before the induction of acute inflammation in the cremaster preparation. These 
experiments revealed that leukocyte emigration was reduced to a similar level as with 
nitrite injection, while no effect on leukocyte adhesion was observed. Thus, emigration 
efficacy was decreased while adhesion was not affected, again indicating separate 
signalling pathways for these steps of the recruitment cascade. Adherent cells crawl 
before they transmigrate out of vasculature (156), and whether nitrate and nitrite affect 
this process remains to be studied. Furthermore, nitrate treatment might also affect the 
endothelial junction proteins, thereby closing the sites for leukocyte transmigration.  
Decreased leukocyte emigration by nitrate was further studied in another inflammatory 
model by diclofenac-induced intestinal damage. Using this model of GI-injury, nitrate 
pretreatment resulted in similar observations as in the acute model with MIP-2, 
demonstrated by lower levels of intestinal MPO and reduced P-selectin expression. In 
agreement with previous studies, a crucial role of oral bacteria in conversion of nitrate to 
nitrite was demonstrated by administrating antiseptic mouthwash during the week of 
nitrate treatment (29). This resulted in loss of nitrate-induced reduction of P-selectin 
expression. These results further show that the nitrate-nitrite-NO pathway indeed has 
profound effects on leukocyte function, a finding that could be of considerable 
importance for several diseases involving inflammation. However, apart from the oral 
bacterial conversion of nitrate, other nitrite reductases might also be important in the 
reduction of nitrite to NO in the intestine (Fig. 1). Nitrate did not increase luminal NO 
levels, which suggests that the effects on leukocyte recruitment are primarily mediated by 
an accumulation of nitrite and other reactive nitrogen intermediates delivered via the 
blood and adjacent cells. Multiple pathways exist for nitrite reduction in tissues and 
blood, including XOR, eNOS and deoxygenated haemoglobin/myoglobin (22). To 
pinpoint the most important reductases of critical importance in this model is indeed 
interesting and will be a goal for future studies.  
4.1.3 Dietary nitrate is not immunosuppressive 
With the reduced leukocyte emigration after nitrate pretreatment observed in both the 
acute and intestinal model of inflammation, we further investigated if the local anti-
inflammatory effects could translate to systemic immune suppression. Neutrophils are 
dominant in the defence against S. aureus infections, so we therefore used these bacteria 
to investigate bacterial clearance. Our results demonstrated that nitrate treatment did not 
reduce the ability to clear subcutaneous S. aureus infections compared to untreated mice. 
This could be explained by the diverse chemotactic gradients that leukocytes are exposed 
to during bacterial infections. A hierarchical relationship between chemotactic factors 
released by bacteria, activated endothelium or leukocytes determine what signalling 
pathways that are induced and thereby the action of the immune cell. Thus, the anti-
inflammatory signals of nitrate and nitrite in response to the low-grade inflammatory 
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stimuli by MIP-2, seems to be totally overridden by the signals from the bacterial 
infection. Hence, nitrite and nitrate can thereby potentially mediate an anti-inflammatory 
condition without the adverse effects associated with immunosuppression therapies.  
4.2 Paper II and III 
Anti-inflammatory effects of nitrate, nitrite and CLA in experimental colitis 
The anti-inflammatory effects of nitrate and nitrite demonstrated in Paper I, were further 
tested in another model of intestinal inflammation by DSS-induced colitis, to further 
study the potentially protective effects of these anions. Anti-inflammatory effects of CLA 
have previously been demonstrated in vitro and in vivo, often partly mediated through 
activation of PPAR-γ (69, 116). Both nitrite and CLA have previously been demonstrated 
to ameliorate experimental colitis (115, 157). However, the clinical relevance of these 
observations in IBD can be questioned, since the treatment is initiated before the 
induction of disease and the levels of treatment are often above recommended intake or 
not achievable by a dietary intake (115, 157). The experimental design of paper II and III 
instead allowed studies of both preventive and therapeutic effects of dietary CLA, nitrite 
and nitrate during DSS-induced colitis. The treatments and disease were induced 
simultaneously, or alternatively the treatment was initiated after DSS induction.   
4.2.1 Preventive effects of nitrate, nitrite and CLA on DSS-induced colitis 
We first investigated if nitrate, nitrite and CLA could have preventive effects on 
inflammation in a model of mild colitis initiated by concurrent administration of 2% DSS 
to Balb/C mice for 7 days (Fig. 10 A). Using this approach, the markers of inflammation 
measured by colon length and DAI-score were clearly improved by nitrite (1mM) in the 
drinking water, and CLA (100mg/kg/d) through the diet. However, administration of 
nitrate (10mM) in the drinking water only demonstrated a reduction in DAI-score while 
no prevention of colon shortening could be observed. Additional investigation of key 
inflammatory markers in the colonic tissue indicated a reduction in the levels of iNOS for 
all treatments studied, while the NF-κB subunit p65 was reduced with nitrate and CLA. 
This further establishes the anti-inflammatory effects seen by the improved colon length 
and DAI-score.  
 
Figure 10. Experimental protocol for investigations of (A) the preventive or (B) 
therapeutic effects of CLA, nitrite and nitrate in DSS-induced colitis in mice. 
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4.2.2 Nitrite has therapeutic effects in established colitis 
Very few studies with anti-inflammatory therapeutic agents have reported efficacy in 
reversing an already existing intestinal inflammation (139). Based on the strong anti-
inflammatory effects of nitrite in the preventive model, we wanted to study if this anion 
could also be protective in an already established disease. DSS (2.5%) treatment was 
initiated for 3 days to induce the disease in mice, followed by 4 days with additional 
nitrite supplementation (Fig. 10 B). After 3 days treatment with DSS, the disease onset 
was determined by a significant aggravation of colitis clinical symptoms, such as 
diarrhoea and rectal bleeding. These markers have previously shown good correlation 
with inflammation in experimental colitis (158). Even with the delay in nitrite treatment, 
improved results of colon length and lower DAI-score was observed, and were similar to 
the effects seen in the preventive experiment of concurrent nitrite administration with 
DSS. The observed anti-inflammatory effects were further confirmed by histological 
examination of the colonic tissue, which revealed that nitrite could partly prevent 
histopathological injuries (colon crypt loss, immune cell influx, and ulceration of the 
epithelial surface) compared to the DSS-treated group. These results are in line with the 
findings in Paper I, indicating that nitrate and nitrite can prevent leukocyte infiltration in 
acute inflammation. Inflammatory responses with enhanced leukocyte and platelet 
aggregation, leading to defects in the microcirculation, have been postulated to play a 
central pathogenic role in development of IBD and in DSS-induced colitis (159, 160). 
Since this model of colitis in some ways resembles human UC, our findings of nitrite 
alleviating DSS-induced colitis may be of clinical importance to ease the inflammatory 
activity and subsequently reduce symptoms (125), although it is generally difficult to 
translate findings in experimental animal models to what is occurring in patients. These 
results suggest that nitrite has an ability to alleviate inflammation even in an initiated 
state of inflammation, thus not only functioning in a preventive manner. 
4.2.3 Insights on the mechanisms behind the anti-inflammatory effects of nitrite and 
CLA 
We continued our studies of nitrite by investigating the effect on colonic mucus thickness 
in DSS-induced colitis, since this layer represents an essential barrier in preventing 
translocation of bacteria and toxins from the colonic lumen to the mucosa (161). This 
protective barrier has been shown to be reduced in patients with IBD and in DSS-treated 
mice (94), indicating that it could be an important target for colitis treatment. Even with 
the delayed administration of nitrite, we observed a complete preservation of the colonic 
mucus thickness compared to the DSS group, reaching the same levels as the control 
mice. This preservation of the mucus barrier could be one of the nitrite-induced protective 
mechanisms by stimulated mucus secretion, and could be mediated by nitrite itself or 
nitrite-derived NO. Previous studies have shown that gastric mucus release is stimulated 
by NO-donors (162, 163), via a mechanism involving activation of sGC and subsequent 
cGMP formation (164). Investigation of the mechanism behind the nitrite mediated 
mucus release needs to be elucidated in further studies.  
To investigate whether the anti-inflammatory effects of nitrite and CLA could be related 
to an increased mucosal healing, we used different approaches. Using colon epithelial 
cells, gene expression of PPAR-γ  and TFF3, respectively involved in broad anti-
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inflammatory effects and epithelial restitution, were investigated after treatment with 
different fatty acids (oleic acid, linoleic acid and CLA). An increased expression of TFF3 
and PPAR-γ was observed after treatment with CLA (2.5 µM). Furthermore, pre-
treatment with the PPAR-γ inhibitor GW9662 reduced the CLA-induced expression of 
both PPAR-γ and TFF3. This indicates that CLA induces PPAR-γ which in turn regulates 
TFF3. In an in vitro model of wound healing in colon epithelial cells, nitrite (100 µM) 
improved healing 24 h after wound incision of a confluent monolayer, indicating that 
nitrite has the ability to increase epithelial restitution. With the demonstrated effect of 
nitrite to sustain mucus thickness after DSS-injury, and since mucins and TFF3 are 
released in co-exocytosis (101), we also investigated whether the expression of TFF3 in 
colonic tissue was induced after nitrite and DSS-treatment. Similar to treatment of CLA, 
nitrite demonstrated a trend towards induced colonic expression of TFF3 (Fig. 11). This 
suggests that upregulation of this peptide might play a role in the anti-inflammatory effect 
seen with both CLA and nitrite. 
 
Figure 11. Quantification (arbitrary units) of colonic TFF3 expression by 
immunohistochemistry staining of mice, (A) treated with or without 2% DSS and nitrite 
(1 mM) or (n=12) (B) treated with or without 2% DSS and CLA (100mg/kg) (n=8) for 7 
days. (P < 0.05,* vs. Control and # vs Control and DSS). Please note that B is taken from 
paper II, (Figure 3D). 
 
Although both nitrite and CLA demonstrate promising results, a great limitation with 
using a chemically-induced model of colitis is that very few substances with anti-
inflammatory effects show similar protection in a more chronic mouse model (139). To 
further investigate the potential protective effect of nitrate, nitrite and CLA in IBD, it is 
necessary to study these substances in more advanced chronic inflammatory models of 
colitis. Also, the effects on the adaptive immune system need to be explored in order to 
evaluate protective properties on more complex and chronic stages of inflammation. A 
recent study demonstrates that NO mediates a suppression of Th17 cells, which are 
associated with the pathogenesis of several autoimmune diseases including IBD (165). 
This indicates that NO and possibly nitrate and nitrite treatment might have effects also 
on other immune cells and in more complex inflammatory models. Furthermore, 
simultaneously with the publication of Paper II, the effect of oral CLA administration 
was investigated in a clinical trial of patients with mild or moderate Crohn’s disease 
(166). The intake of 6g/day CLA decreased the disease activity and resulted in reduced 
lymphocyte production of pro-inflammatory cytokines after 12 weeks. Interestingly, this 
                                                                                                   Results and discussion 
 
29 
 
dose is equivalent per kilogram body weight to the one we administered by the diet to the 
mice. Future studies are needed to investigate the importance of TFF3-induction and 
eventual mucosal healing by CLA in IBD. Figure 12 summarizes the suggested protective 
pathways mediated by CLA and nitrite in DSS-induced colitis.   
 
Figure 12. Proposed pathways of protection by CLA and nitrite in DSS-induced colitis.  
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4.3 Paper IV 
Physiological recycling of endogenous nitrate by oral bacteria regulates gastric 
mucus thickness 
The observation of nitrate accumulation in saliva from the circulation, and its reduction to 
nitrite by the oral bacteria to generate NO in the acidic gastric lumen, suggests an 
important role for maintaining homeostasis also in the upper GI tract. However, the 
physiological role of endogenously produced nitrate and nitrite coming from NOS is still 
not clear. It is tempting to speculate that the entero-salivary nitrate cycle described above 
serves as a salvage pathway to regenerate NO that would otherwise be lost through 
metabolism and excretion. In an attempt to study this, we used germ free mice and 
studied the gastric mucus generation in response to nitrate and nitrite. 
4.3.1 Recycling of endogenous nitrate is important for regulation of the gastric 
mucus layer 
Earlier studies have indicated that both the oral and gastrointestinal microflora have a 
central role in regulating generation of gastric NO (29, 167). The results from this study 
clearly show that even nitrite, at levels simulating those originating from NOSs alone, has 
profound effects on the gastric mucosa by increasing the firmly adherent mucus layer. 
While untreated germ free mice almost lacked adherent mucus layer, nitrite in doses 
ranging from high dietary to physiological levels increased mucus thickness to the same 
extent. In contrast, nitrate administration to germ free mice had no effect on regulation of 
mucus thickness, again demonstrating the pivotal role of bacteria in bioactivation of this 
anion. The importance of recycling endogenous nitrate has recently been investigated in a 
human study, where the subjects were treated with antibacterial mouthwash together with 
a nitrate low diet (36). The results showed that the plasma levels of nitrite decreased in 
correlation with an increase in blood pressure, indicating that endogenous nitrate 
recycling is essential for physiological control of blood pressure. Furthermore, a very 
recent study suggests that a cross-talk between the nitrate-nitrite-NO pathway and the 
NOS-dependent pathway exist in the vasculature (168). This would favour the  control of 
vascular NO homeostasis and maintain levels of NO at physiological concentrations.  
We now have indications that broad spectrum antibiotics also reduce the adherent gastric 
mucus layer although the effect was not as dramatic as in germ free mice. Treatment with 
antibiotics completely eradicated the colonic microflora, while the oral flora was still 
present and able to reduce nitrate to nitrite. This might be the explanation to the observed 
relatively thick gastric mucus layer compared to germ free mice. However, the 
consequence of a reduced gastric mucus layer against induced injury has not been fully 
elucidated. 
Our present results show that regulation of the firmly adherent gastric mucus layer is 
influenced by signalling mechanisms through nitrite generated by the oral microflora. 
Interestingly, the effect of nitrite in the regulation of gastric mucus thickness does not 
seem to be mediated by the activation of the sGC-cGMP pathway, which is opposite to 
what has been observed in its regulation of gastric mucosal blood flow (47). The cGMP-
independent mechanism observed in this study might instead favour the existence of 
alternative nitrite signalling pathways that can only be speculated on at this stage. 
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Alterations of protein function could be mediated by nitrite through the formation of S-
nitrosothiols or by nitration through the nitrogen dioxide radical (58, 169). It would be 
interesting to measure the levels of these substances in the mucus from nitrite treated 
animals to see if this might be a relevant signalling pathway. However, the amount of 
mucus that can be obtained from a mouse is extremely small, and the S-nitrosothiols 
formed are very reactive and volatile. Another interesting signalling mechanism to 
explore is whether nitrite itself, like some other bacterial products, can mediate 
intracellular signalling through toll-like receptors (TLRs). TLRs are important not only in 
protection against pathogenic infections. In fact, it has been demonstrated recently that 
normal commensal bacteria are recognized by TLRs, which in turn serve to mildly 
activate the immune system thereby regulating epithelial homeostasis and protecting 
against gut injury (146). By the use of a TLR4 receptor agonist in germ free mice or mice 
deficient in MyD88 or TLR4, such possible involvement of nitrite in gastric mucus 
regulation could be addressed.     
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5 CONCLUSIONS 
 Inorganic nitrate and nitrite reduce leukocyte recruitment during acute 
inflammation.  
 Dietary nitrate has potent anti-inflammatory effects in NSAID-provoked 
intestinal injury in a process involving reduction of MPO and P-selectin levels. 
 Nitrate effects proceed via intermediate formation of nitrite, a reaction involving 
oral nitrate-reducing bacteria. 
 Despite being anti-inflammatory, dietary nitrate does not impair bacterial 
clearance.  
 
 Dietary CLA attenuates DSS-induced colitis, partly mediated by an upregulation 
of TFF3 expression through activation of PPARγ in colon epithelial cells 
 
 Inorganic nitrate and nitrite alleviate DSS-induced colitis. 
 Dietary nitrite has therapeutic effects also in already established colonic 
inflammation. 
 Dietary nitrite mediates the protective effects by prevention of DSS-induced 
thinning of the colonic mucus layer, and promotes healing of colon epithelial 
cells. 
 
 Germ free mice are almost completely devoid a firmly adherent gastric mucus 
layer. 
 Physiological levels of nitrite restore gastric mucus thickness through a cGMP-
independent mechanism. 
 The gastric mucus layer is reduced by treatment with broad spectrum antibiotics 
in mice. 
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6 GENERAL DISCUSSION AND FUTURE PERSPECTIVES  
The fact that green leafy vegetables, which contain high amounts of nitrate, are now 
considered to be the top choice of vegetables for improved health is intriguing since 
nitrate ironically has been targeted as the only harmful natural substance in this food 
group. Emerging data from animal and human studies support the hypotheses that nitrate 
is an active substance in vegetables contributing to their positive health effects. In 
addition to this, the still unknown reason for the active accumulation of nitrate in saliva 
observed in the 1970s suggests that there is indeed something important with this anion 
for general physiological regulation and homeostasis. 
In this thesis I have explored the new area of anti-inflammatory effects by nitrate, nitrite 
and CLA. The present studies demonstrate that specific components in our diet play a 
direct role in regulating acute inflammatory responses, both in the microcirculation and in 
the gastrointestinal tract. Therapeutic opportunities for dietary nitrite have been further 
indicated in a model of already established colonic inflammation, an effect partly 
mediated by nitrite-derived NO. We also show the potential importance of recycling 
endogenously produced nitrate in regulating gastric homeostasis, a process dependent on 
oral nitrate reducing bacteria. These results lead to additional interesting questions to be 
addressed, and further studies of nitrate, nitrite and CLA in inflammatory reactions are 
called for. Can these therapies also affect adaptive immune cells and chronic 
inflammation? Furthermore, several studies indicate that nitrate and nitrite have profound 
effect on gastric mucosal homeostasis, and are important for maintaining a proper gastric 
mucus layer. Exactly how salivary-derived nitrite regulates gastric mucus secretion is still 
unknown, as is to which extent the gastric mucus layer is essential for protection of 
gastric injury. 
There are promising future therapeutic opportunities for dietary nitrate and nitrite in 
various conditions. The most appreciated areas for therapy have been correlated with 
cardiovascular disorders such as hypertension, endothelial dysfunction and ischemia-
reperfusion injury. However, other pathophysiological conditions where nitrate and nitrite 
might have beneficial effects are also receiving increased attention, including infection, 
inflammation and metabolic diseases such as diabetes (53-55, 170-172). Importantly, 
although many initial studies show promising therapeutic applications with dietary nitrate 
(44, 173), there are also examples in clinical trials where this type of treatment does not 
seem to have an effect (174). There is a future need to delineate how nitrate and nitrite are 
affecting different patients and determine which factors are important for successful 
treatment. Also, the importance of vegetables high in nitrate needs to be further explored. 
Larger long-term clinical studies are clearly needed in order to further examine the 
potential for nitrate and nitrite in prevention and treatment of diseases. Even with the 
great potential of possible important preventive effects for entire populations, these costly 
studies are difficult to conduct in reality mainly due to the lack of interest from by the 
pharmaceutical industry. The intellectual property is hard to defend since these anions are 
chemically simple, cheap and readily available. However, the value of health 
improvements for the society as a whole might be extensive and should not be neglected.
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7 POPULÄRVETENSKAPLIG SAMMANFATTNING  
7.1 Bakgrund 
Det är idag ställt utom allt tvivel att maten vi äter har en mycket stor påverkan på vår 
hälsa. En traditionell medelhavskost med stort intag av bl.a grönsaker och omättade fetter 
har visat sig kunna skydda mot uppkomst av en rad sjukdomar inklusive 
hjärtkärlsjukdomar och typ 2-diabetes. Det är dock fortfarande inte klarlagt vilka delar i 
kosten som ger detta skydd. Antioxidanter, fibrer, mineraler och vitaminer tros ha 
betydelse, men studier av enskilda näringsämnen har hittills inte gett tydliga resultat.   
Vissa typer av grönsaker innehåller stora mängder nitrat (NO3
-
), såsom rödbetor, sallad 
och spenat. Merparten av det nitrat vi äter tas upp i tunntarmen och transporteras sedan 
vidare till blodet. Därifrån koncentreras nitrat till spottkörtlarna via en aktiv process vilket 
medför att vår saliv innehåller en mycket hög halt nitrat. Den nitratrika saliven omvandlas 
av bakterier i munhålan till nitrit (NO2
-
) som sväljs ner till magsäcken. Nitrit i magsäcken 
kommer i sin tur att reduceras till kväveoxid (NO) vid kontakt med den sura magsaften. 
En viss del av den nitrit vi sväljer kan också undkomma denna reduktion och istället tas 
upp till blodet och vävnader där nitrit kan reduceras till NO genom ett antal enzym. NO är 
en viktig biologisk signalmolekyl som styr många fysiologiska funktioner i kroppen, t.ex. 
kärlvidgning, signalering mellan nerver och immunförsvar mot infektioner. Att NO kan 
bildas från nitrat i kosten är en relativt ny upptäckt, medan man längre har vetat att NO 
kan produceras av kroppen själv genom specifika enzym, så kallade NO syntas (NOS). 
Detta NO kan sedan omvandlas till nitrit och nitrat i blod och vävnader och därmed 
blanda sig med nitrat och nitrit som härstammar från kosten. I våra kroppar finns alltså ett 
system där nitrat, nitrit och NO kan ombildas till varandra i ett spännande kretslopp. Att 
kunna öka kroppens tillgång på NO genom kosten kan vara intressant då många 
hjärtkärlsjukdomar delvis tros bero på en bristande NO bildning från kroppens egna NOS. 
En grönsaksrik kost har visat sig vara skyddande mot uppkomst hjärtkärlsjukdomar 
såsom hypertoni, och det har nyligen föreslagits att just nitrat i dessa grönsaker kan vara 
en viktig bidragande orsak. Forskningen runt kostrelaterat nitrat och nitrit har ökat enormt 
de senaste decennierna och främst fokuserat på sjukdomar rörande hjärtkärlsjukdomar 
och magsår. Studier har också visat att NO bildat från NOS har stor betydelse i 
immunologiska reaktioner som inflammation, men det är inte känt hur nitrat och nitrit kan 
påverka dessa processer. Rekrytering av vita blodkroppar (leukocyter) från blodet till 
angripen vävnad är en central händelse i det tidiga inflammatoriska förloppet, t.ex. vid en 
bakterieinfektion. Denna process sker i flera steg och styrs av olika mediatorer som 
frisätts från vävnaden till blodet. Detta medför att leukocyterna fastnar i blodkärlen och 
sedan vandrar ut från blodbanan till det inflammerade området för att bekämpa 
infektionen. Även om denna process är avgörande för ett välfungerande skydd mot farliga 
infektioner så kan det också leda till skadlig kronisk inflammation.  
Förutom NO har även en rad andra ämnen en viktig betydelse vid inflammatoriska 
reaktioner. Ett exempel är fettsyror, som kan agera som signalämnen och förmedla pro- 
eller anti-inflammatoriska effekter. En särskild typ av fettsyra, konjugerad linolensyra 
(CLA), finns naturligt i mejeriprodukter och kött från idisslande djur och har nyligen 
visat sig kunna minska inflammation i experimentell tarmsjukdom. Även om anti-
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inflammatoriska effekter har påvisats så vet man fortfarande lite om hur denna 
signalering sker.  
Det övergripande syftet med studierna i denna avhandling var att undersöka hur nitrat, 
nitrit och CLA via kosten påverkar fundamentala funktioner och inflammatoriska 
processer i magtarmkanalen.   
7.2 Resultat och diskussion  
I det första delarbetet (Paper I) undersökte vi hur en nitratrik kost kan påverka 
rekryteringen av leukocyter till en inflammerad vävnad. För att studera detta 
förbehandlades möss med nitrat och nitrit följt av analyser av vita blodkroppar i blodkärl i 
en tunn muskel med hjälp av mikroskopi. Inflammation stimulerades genom tillsats av en 
inflammatorisk substans (MIP-2, macrophage inflammatory protein-2) som attraherar 
leukocyter. Resultaten visade att både nitrat och nitrit kunde minska aktiveringen av 
leukocyterna och därmed minska antalet celler som tog sig ut från blodet till vävnaden. 
Vidare resultat visade att detta kan bero på en nedreglering att specifika 
adhesionsmolekyler på blodkärlens yta (ICAM-1, intracellular adhesion molecule type 1) 
som annars leder att leukocyter fastnar och vandrar genom blodkärlet. Effekten av nitrat 
från kosten på leukocytrekrytering undersöktes vidare i en annan kliniskt relevant modell. 
Behandling med vissa anti-inflammatoriska läkemedel (NSAIDs, nonsteroidal anti-
inflammatory drugs) medför ofta biverkningar i form av retningar och sår i 
magtarmkanalen. Genom att ge möss ett sådant läkemedel (diclofenac) efter 
förbehandling med nitrat, studerades graden av inflammation i den första delen av 
tunntarmen. Nitrat visade sig även här kunna minska infiltration av leukocyter till vävnad 
samt nedreglera andra typer av adhesionsmolekyler (P-selektin) på blodkärlens yta. 
Ytterligare försök där råttor gavs en antibakteriell munsköljvätska visade att denna 
skyddande effekt var helt beroende av bakterierna i munhålan som omvandlar nitrat till 
nitrit. Slutligen undersökte vi om effekten av en minskad aktivering av leukocyter efter 
ett inflammatoriskt stimuli vid intag av nitrat kunde medföra att immunförsvaret även blir 
sämre på att bekämpa en riktig bakterieinfektion. Detta studerades genom att 
luminicerande Stafylococcus aureus-bakterier injicerades under huden i kontroll- och 
nitratbehandlade möss, där läkningen av infektionen observerades under 14 dagar. Trots 
att nitrat visade sig ha en anti-inflammatorisk effekt vid mild stimulering av inflammation 
så gav det inte upphov till en försämrad förmåga att bekämpa en allvarlig 
bakterieinfektion. Slutsatsen av denna studie visar att nitrat via kosten kan ge anti-
inflammatoriska effekter utan att medföra oönskade biverkningar i form av ökad risk för 
infektioner. 
Syftet med det andra och tredje delarbetet (Paper II, III) var att undersöka de anti-
inflammatoriska effekterna av dietärt nitrat, nitrit och CLA vid experimentell 
tarmsjukdom. Inflammatorisk tarmsjukdom hos människor innefattar sjukdomarna 
Crohns sjukdom och Ulcerös kolit. Det drabbar nästan 1% av norra Europas befolkning 
och klassas därmed som en folksjukdom. Detta är en livslång och idag obotlig sjukdom 
som ger upphov till tarminflammation och tros bero på en förlorad tolerans mot vår 
tarmflora. I dessa studier användes en vanlig modell av denna sjukdom där möss ges det 
sjukdomsinducerade medlet DSS (dextran sulfate sodium) som leder till inflammation i 
tjocktarmen. Resultaten visade att främst CLA och nitrit, men även nitrat till en viss grad, 
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kunde lindra kliniska symptom och inflammatoriska processer i denna modell av 
inflammatorisk tarmsjukdom. Även tjocktarmsceller odlade i kultur studerades för att 
lättare kunna undersöka aktivering av olika anti-inflammatoriska signalvägar. Genom att 
studera effekterna av CLA i både celler och tjocktarmsvävnad från möss, kunde vi se att 
CLA troligtvis har skyddande effekt genom en aktivering av de anti-inflammatoriska 
signalvägarna PPAR-γ (peroxisome proliferator-activated receptor gamma) och TFF3 
(trefoil factor 3). Dessa signalvägar är essentiella i läkningsprocessen av cellskador i 
magtarmkanalen. För att vidare studera huruvida den anti-inflammatoriska effekten av 
nitrit vid tarmsjukdom även kunde skydda vid en redan etablerad inflammation, gavs 
behandling med nitrit till möss tre dagar efter start av DSS. Även denna fördröjning av 
nitritbehandling visade liknande anti-inflammatoriska effekter som när nitrit gavs 
samtidigt med DSS. Den skyddande effekten av nitrit visade sig kunna bero på förmågan 
att öka tjockleken av det skyddande slemlagret i tjocktarmen som fungerar som en barriär 
mellan bakterier och cellvägg i tarmen. Vidare studier på tjocktarmsceller visade att nitrit 
också kunde förbättra läkningen av inducerade sår, vilket tros vara en viktig faktor för att 
även mildra symptomen av inflammatorisk tarmsjukdom hos människa.  Dessa två studier 
visar att dietärt CLA, nitrit och till viss del nitrat, kan lindra inflammatorisk tarmsjukdom 
hos möss. Nitrit visade sig även ha terapeutiska effekter i denna modell. Dessa resultat 
kan ha viktig betydelse för framtida kostrekommendationer i behandlingen av 
inflammatorisk tarmsjukdom hos människa.  
Under de senaste decennierna har många studier visat effekter av ett extra tillskott av 
nitrat och nitrit via kosten på olika aspekter av hälsa och sjukdom. Mycket mindre 
studerat är hur kroppens egenproducerade nivåer av nitrat och nitrit från NOS påverkar 
regleringen av olika fysiologiska funktioner. I delarbete fyra (Paper IV) undersöktes 
rollen av kroppens egna nivåer av nitrat och nitrit på magslemhinnan. Dessa effekter 
studerades i bakteriefria möss som inte kan omvandla nitrat till nitrit via bakterier i 
munhålan, och därför inte heller kan bilda NO i magsäcken. Detta gör det möjligt att 
istället ge dessa möss olika doser av nitrit för att efterlikna det nitrit som annars normalt 
sväljs ner under hela dygnet. Resultaten visade att bakteriefria möss hade ett extremt tunt 
slemlager i magsäcken, medan även mycket låga nivåer av nitrit hade betydande effekter 
genom att kraftigt öka detta slemlager. Eftersom bakteriefria möss uppvisade ett mycket 
tunt slemlager, undersökte vi huruvida detta även kunde påvisas i en annan kliniskt 
relevant modell genom behandling av möss med bredspektrumantibiotika. Intressant nog 
visade sig dessa djur också ha ett tunnare slemlager i magsäcken jämfört med 
kontrollmöss, även om effekten inte var lika stor som hos de bakteriefria mössen. 
Behandling med antibiotika slog helt ut bakteriefloran i tarmen medan bakterierna i 
munhåla fortfarande existerade med förmåga att reducera nitrat till nitrit. Detta kan 
förklara varför antibiotikabehandlade möss fortfarande har ett relativt tjockt slemlager. 
Betydelsen av en minskad slemtjocklek i magsäcken för en ökad känslighet för magsår är 
ännu inte fastställd. Fortsatta studier bör genomföras för att utröna betydelsen av detta 
slemlager vid en ökad påfrestning av magslemhinnan. Dessa resultat visar att även 
fysiologiska nivåer av nitrit som kan bildas av orala bakterier är viktiga i regeleringen av 
slemtjockleken i magsäcken. Detta tyder på att återvinning av nitrat som bildas genom 
NO av NOS är viktigt att upprätthålla en väl fungerande magslemhinna. 
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7.3 Sammanfattning 
Resultaten i denna avhandling pekar på att specifika komponenter i vår kost spelar en 
direkt roll i regleringen av inflammatoriska reaktioner, både på lokal nivå i små blodkärl 
och på organnivå i magtarmkanalen. Terapeutiska möjligheter har även påvisats av dietärt 
nitrit i en etablerad modell av tarminflammation, en effekt som delvis förmedlades av 
NO. Kroppseget nitrat, som från början är bildat via NOS, har också en viktig roll i 
regleringen av en väl fungerande magslemhinna, en process som är beroende av bakterier 
i munhålan som kan omvandla nitrat till nitrit. 
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